Legend Biotech Insider to Sell $33K in Shares Following Restricted Stock Vesting

Legend Biotech Corporation insider Patrick Casey has filed Form 144 indicating intent to sell 1,000 American Depositary Shares (ADS) through Fidelity Brokerage Services.

Rhea-AI Filing Summary

Legend Biotech Corporation insider Patrick Casey has filed Form 144 indicating intent to sell 1,000 American Depositary Shares (ADS) through Fidelity Brokerage Services. The proposed sale has an aggregate market value of $33,234.

The securities to be sold were originally acquired on June 20, 2022 through restricted stock vesting as compensation. The filing indicates that Casey has previously sold 1,000 ADS on June 6, 2025, for gross proceeds of $32,320.

Key transaction details:

• Total outstanding shares: 367,298,315
• Planned sale date: June 26, 2025
• Trading venue: NASDAQ
• Average price per share: $33.23

This Form 144 represents a standard insider sale notification, required when affiliates intend to sell restricted or control securities, and affirms no knowledge of undisclosed material adverse information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LEGN shares are being sold by insiders according to the June 2025 Form 144?

According to the Form 144 filing dated June 28, 2025, an insider plans to sell 1,000 American Depositary Shares of Legend Biotech (LEGN) through Fidelity Brokerage Services LLC, with an aggregate market value of $33,234.00.

When did the LEGN insider originally acquire the shares being sold?

The shares being sold were originally acquired on June 20, 2022 through Restricted Stock Vesting as part of compensation from the issuer (Legend Biotech).

What is the total number of LEGN shares outstanding as of June 2025?

According to the Form 144 filing, Legend Biotech (LEGN) had 367,298,315 shares outstanding at the time of the filing in June 2025.

Has the LEGN insider made any other sales in the past 3 months?

Yes, according to the filing, Patrick Casey of Somerset, NJ sold 1,000 American Depositary Shares on June 6, 2025, generating gross proceeds of $32,320.00.

What is the planned date of sale for the LEGN shares in this Form 144?

The Form 144 indicates that the approximate date of sale for the 1,000 American Depositary Shares is June 26, 2025, and they will be sold on the NASDAQ exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2025 - 11:21 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002068365
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Legend Biotech Corp
SEC File Number	001-39307
Address of Issuer	2101 COTTONTAIL LANE SOMERSET NEW JERSEY 08873
Phone	732-850-5598
Name of Person for Whose Account the Securities are To Be Sold	Casey Patrick John
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1000	33234.00	367298315	06/26/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
American Depositary Shares	06/20/2022	Restricted Stock Vesting	Issuer			1000	06/20/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Patrick Casey 2101 Cottontail Lane Somerset NJ 08873	American Depositary Shares	06/06/2025	1000	32320.00

144: Remarks and Signature

Remarks
Date of Notice	06/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Patrick Casey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)